Miproxifene
CAS: 129612-87-9
Rif. 3D-EFA61287
1mg | Prezzo su richiesta | ||
5mg | Prezzo su richiesta | ||
10mg | Prezzo su richiesta | ||
25mg | Prezzo su richiesta | ||
50mg | Prezzo su richiesta |
Informazioni sul prodotto
- (Z)-alpha-(p-(2-(Dimethylamino)ethoxy)phenyl)-alpha'-ethyl-4'-isopropyl-4-stilbenol
- 2-Oh-Dm-Dp
- 4-[(1Z)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-buten-1-yl]phenol
- 4-{(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-[4-(1-methylethyl)phenyl]but-1-en-1-yl}phenol
- DP-Tat-59
- Miproxifene [INN]
- Phenol, 4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-(4-(1-methyletthyl)phenyl)-1-butenyl)-, (Z)-
- Phenol, 4-[(1Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-buten-1-yl]-
- Phenol, 4-[(1Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-butenyl]-
- Phenol, 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-butenyl]-, (Z)-
- Vedi altri sinonimi
- Unii-Bgj4Z7930W
Miproxifene is a potent anticancer drug that has been shown to induce apoptosis and inhibit cell cycle progression in human cancer cells. This drug has been extensively studied in Chinese hamster ovary (CHO) cells and has demonstrated significant activity against various types of cancer, including leukemia. Miproxifene acts as a protein inhibitor and has been found to be effective against several tumor cell lines. It is a promising medicinal compound for the treatment of cancer, with potential applications in both chemotherapy and radiation therapy. Miproxifene is excreted primarily through urine and is well-tolerated by patients. Its use as an anticancer agent holds great promise for the future of cancer treatment.
Proprietà chimiche
Richiesta tecnica su: 3D-EFA61287 Miproxifene
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.